$379.50
27.62 (-6.78%)
Last updated: Jul 15, 2026 06:56
Fundamentals Overview
Intuitive Surgical, Inc. is near the low of its 52-week range with premium valuation, experiencing significant downward pressure today.
Valuation premium
Intrinsic value (DCF)
-66.5% downside vs price
Profitability
Risk (Beta)
1.46 — higher vol
Earnings & growth
BullzEye Analysis
Our composite tilts Sell on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
Analyst grade: B- · Sentiment improving (3 upgrades)
Pressures (Sell):
DCF 66.5% downside vs price · 3M vs S&P 500: -26.9% · 3M vs Healthcare sector: -24.3% · Beta 1.46 (elevated)
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: B-. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 12, In Line: 3, Neutral: 5, Outperform: 5, Overweight: 5.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $127.12; current price is $379.50. That’s a -66.5% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 45.83 |
| DCF value (model) | $127.12 (-66.5% vs price) |
| PEG (TTM) | 2.26 |
| P/B (TTM) | 7.71 |
| P/S (TTM) | 12.7 |
| P/FCF (TTM) | 47.42 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 6.03 |
| Quick Ratio (TTM) | 5.01 |
| Cash Ratio (TTM) | 1.07 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 28.15% |
| Gross margin (TTM) | 66.29% |
| Operating margin (TTM) | 30.45% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for ISRG.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Evercore ISI Group | maintain | In Line | In Line | 2026-07-06 |
| B of A Securities | maintain | Buy | Buy | 2026-05-18 |
| Barclays | maintain | Overweight | Overweight | 2026-04-23 |
| Baird | maintain | Outperform | Outperform | 2026-04-22 |
| BTIG | maintain | Buy | Buy | 2026-04-22 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-04-22 |
| Leerink Partners | maintain | Outperform | Outperform | 2026-04-22 |
| Truist Securities | maintain | Buy | Buy | 2026-04-15 |
| Mizuho | maintain | Neutral | Neutral | 2026-04-13 |
| BTIG | maintain | Buy | Buy | 2026-04-10 |
| Goldman Sachs | maintain | Buy | Buy | 2026-04-09 |
| Evercore ISI Group | maintain | In Line | In Line | 2026-04-06 |
| UBS | maintain | Neutral | Neutral | 2026-03-17 |
| Citigroup | upgrade | Neutral | Buy | 2026-03-11 |
| UBS | maintain | Neutral | Neutral | 2026-02-24 |
| Freedom Capital Markets | upgrade | Hold | Buy | 2026-01-27 |
| Barclays | maintain | Overweight | Overweight | 2026-01-26 |
| Freedom Broker | upgrade | Hold | Buy | 2026-01-26 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-01-23 |
| Citigroup | maintain | Neutral | Neutral | 2026-01-23 |
| Bernstein | maintain | Outperform | Outperform | 2026-01-23 |
| BTIG | maintain | Buy | Buy | 2026-01-23 |
| Evercore ISI Group | maintain | In Line | In Line | 2026-01-23 |
| Bernstein | maintain | Outperform | Outperform | 2026-01-09 |
| BTIG | maintain | Buy | Buy | 2026-01-07 |
| Barclays | maintain | Overweight | Overweight | 2026-01-07 |
| Truist Securities | maintain | Buy | Buy | 2025-12-18 |
| RBC Capital | maintain | Outperform | Outperform | 2025-12-17 |
| Citigroup | downgrade | Buy | Neutral | 2025-12-11 |
| Freedom Broker | maintain | Buy | Buy | 2025-10-28 |